Table 3.
Fulfilment of ASAS axSpA criteria | ||||
---|---|---|---|---|
SPACE | DESIR | |||
OR (95% CI) | P- value | OR (95% CI) | P- value | |
Any PFH | 2.1 (1.4-3.1) | <0.001 | 1.3 (1.0-1.9) | 0.091 |
AS | 3.3 (2.0-5.3) | <0.001 | 2.1 (1.3-3.3) | <0.001 |
AAU | 7.4 (2.5-21.7) | <0.001 | 5.0 (1.5-16.7) | 0.009 |
ReA | 0.6 (0.2-1.9) | 0.421 | 0.3 (0.05-1.5) | 0.132 |
IBD | 1.1 (0.5-2.2) | 0.798 | 0.8 (0.4-1.6) | 0.521 |
Psoriasis | 1.2 (0.8-2.0) | 0.388 | 1.2 (0.8-1.8) | 0.464 |
Any PFH, any family history manifestation in first- or second-degree relatives; AS ankylosing spondylitis, AAU acute anterior uveitis, ReA reactive arthritis, IBD inflammatory bowel disease, OR odds ratio, 95% CI 95% confidence interval